Aldeyra Therapeutics (137.F) Q2 2024 Earnings

May 2Confirmed
Q4 2023
Q2 2024
-0.13
-0.11
-0.09
-0.07

Details

Expected EPS
-0.1031135625
Actual EPS
-0.13049400000000003
Surprise EPS
-0.03
Surprise Percent
-26.55%

Description

⁨Aldeyra Therapeutics⁩ (⁦137.F⁩) has reported earnings of ⁦-0.13049400000000003⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts